Vaxxa AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2022	FY 2021
Period Ending	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-51.14	-12.83
Depreciation & Amortization	10.75	2.62
Other Amortization	0.31	-
Asset Writedown & Restructuring Costs	31.97	-
Other Operating Activities	0	4.32
Change in Accounts Receivable	0.47	-0.59
Change in Accounts Payable	-0.08	0.04
Change in Other Net Operating Assets	5.56	-0.37
Operating Cash Flow	-2.16	-6.82
Capital Expenditures	-0.13	-
Sale (Purchase) of Intangibles	-21.16	-0.06
Investing Cash Flow	-21.29	-0.06
Long-Term Debt Issued	3.25	-
Net Debt Issued (Repaid)	3.25	-
Issuance of Common Stock	19.13	6.74
Financing Cash Flow	22.38	6.74
Net Cash Flow	-1.07	-0.14
Free Cash Flow	-2.29	-6.82
Free Cash Flow Margin	-	-143.64%
Free Cash Flow Per Share	-1.25	-10.88
Cash Income Tax Paid	0.27	-
Levered Free Cash Flow	-8.73	-5.8
Unlevered Free Cash Flow	-8.58	-2.88
Change in Working Capital	5.95	-0.93

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.